ArticleCureus2026
Stellate Ganglion Block for the Management of Cannabis Use Disorder: A Case Series.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, there are no approved or consistently effective pharmacological treatments for managing cannabis use disorder. Three patients diagnosed with cannabis use disorder and presenting with cannabis withdrawal syndrome were assessed by an interdisciplinary team. These patients were treated with two-level dual stellate ganglion blocks. Validated patient-reported outcome measures were completed. Urine cannabis levels were measured at the four-week follow-up. At one-, two-, and four-week reviews, all three patients reported reduced withdrawal symptoms. Urine cannabis tests were negative at the four-week review. Limitations include a small cohort of patients, absence of a control arm, and possible placebo effects. Stellate ganglion block could have a role in the management of cannabis use disorder and cannabis withdrawal syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.